Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
David Steinberg's Stock Ratings
Jefferies Analyst
David Steinberg is an analyst at Jefferies. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/24/2025
Overall Average Return
17.9%
Smart Score
Overall Average Return Percentile
77th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 02/06/2025 | BHC | Buy Now | Bausch Health Companies | $4.46 | 79.37% | David Steinberg66% | $12 → $8 | Downgrade | Buy → Hold | Get Alert |
| 09/20/2023 | BHC | Buy Now | Bausch Health Companies | $4.46 | 258.74% | David Steinberg66% | $9 → $16 | Upgrade | Hold → Buy | Get Alert |
| 05/22/2023 | BHC | Buy Now | Bausch Health Companies | $4.46 | 113% | David Steinberg66% | $7 → $9.5 | Maintains | Buy | Get Alert |
| 10/01/2021 | BHC | Buy Now | Bausch Health Companies | $4.46 | 729.6% | David Steinberg66% | $37 → $37 | Maintains | Buy | Get Alert |
| 09/30/2021 | PRGO | Buy Now | Perrigo | $26.56 | 137.2% | David Steinberg66% | $45 → $63 | Upgrade | Hold → Buy | Get Alert |
| 06/03/2021 | BHC | Buy Now | Bausch Health Companies | $4.46 | 729.6% | David Steinberg66% | → $37 | Maintains | Buy | Get Alert |
| 04/13/2021 | SUPN | Buy Now | Supernus Pharmaceuticals | $32.10 | 24.61% | David Steinberg66% | $25 → $40 | Upgrade | Hold → Buy | Get Alert |
| 02/17/2021 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Steinberg66% | $103 → $120 | Maintains | Buy | Get Alert |
| 01/15/2021 | BHC | Buy Now | Bausch Health Companies | $4.46 | 639.91% | David Steinberg66% | $27 → $33 | Maintains | Buy | Get Alert |
| 10/09/2020 | JAZZ | Buy Now | Jazz Pharmaceuticals | $114.45 | 64.26% | David Steinberg66% | $151 → $188 | Maintains | Buy | Get Alert |
| 06/15/2020 | SUPN | Buy Now | Supernus Pharmaceuticals | $32.10 | -25.23% | David Steinberg66% | → $24 | Reinstates | → Hold | Get Alert |
| 04/28/2020 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Steinberg66% | $47 → $51 | Maintains | Buy | Get Alert |
| 04/23/2020 | BHC | Buy Now | Bausch Health Companies | $4.46 | 505.38% | David Steinberg66% | $35 → $27 | Maintains | Buy | Get Alert |
| 04/06/2020 | JAZZ | Buy Now | Jazz Pharmaceuticals | $114.45 | 30.19% | David Steinberg66% | → $149 | Initiates | → Buy | Get Alert |
| 03/17/2020 | OCUL | Buy Now | Ocular Therapeutix | $7.30 | 9.59% | David Steinberg66% | → $8 | Initiates | → Buy | Get Alert |
| 11/06/2019 | SUPN | Buy Now | Supernus Pharmaceuticals | $32.10 | — | David Steinberg66% | — | Downgrade | Buy → Hold | Get Alert |
| 08/09/2018 | SUPN | Buy Now | Supernus Pharmaceuticals | $32.10 | 80.69% | David Steinberg66% | $55 → $58 | Maintains | Buy | Get Alert |
| 08/09/2018 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Steinberg66% | $21 → $23 | Maintains | Buy | Get Alert |
| 06/14/2018 | SCPH | Buy Now | scPharmaceuticals | $3.50 | 243.32% | David Steinberg66% | $26 → $12 | Maintains | Buy | Get Alert |
| 12/12/2017 | SCPH | Buy Now | scPharmaceuticals | $3.50 | 558.03% | David Steinberg66% | → $23 | Initiates | → Buy | Get Alert |
| 11/07/2017 | OPTN | Buy Now | OptiNose | $9.65 | 179.79% | David Steinberg66% | → $27 | Initiates | → Buy | Get Alert |
| 11/07/2017 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Steinberg66% | $16 → $21 | Maintains | Buy | Get Alert |
| 11/03/2017 | INSY | Buy Now | Insys Therapeutics | — | — | David Steinberg66% | $14 → $11 | Maintains | Buy | Get Alert |
| 09/22/2017 | SVRA | Buy Now | Savara | $2.89 | 592.04% | David Steinberg66% | → $20 | Initiates | → Buy | Get Alert |
| 04/25/2017 | AKRX | Buy Now | Akorn | — | — | David Steinberg66% | — | Downgrade | Buy → Hold | Get Alert |
| 10/10/2016 | INSY | Buy Now | Insys Therapeutics | — | — | David Steinberg66% | — | Maintains | Buy | Get Alert |
| 08/11/2016 | PRGO | Buy Now | Perrigo | $26.56 | 216.27% | David Steinberg66% | $97 → $84 | Maintains | Hold | Get Alert |
| 08/04/2016 | SUPN | Buy Now | Supernus Pharmaceuticals | $32.10 | -12.77% | David Steinberg66% | $23 → $28 | Maintains | Buy | Get Alert |
| 08/04/2016 | INSY | Buy Now | Insys Therapeutics | — | — | David Steinberg66% | $17 → $22 | Maintains | Buy | Get Alert |
| 05/13/2016 | PRGO | Buy Now | Perrigo | $26.56 | 265.21% | David Steinberg66% | $112 → $97 | Maintains | Hold | Get Alert |
| 05/12/2016 | SUPN | Buy Now | Supernus Pharmaceuticals | $32.10 | -28.35% | David Steinberg66% | $19 → $23 | Maintains | Buy | Get Alert |
| 04/26/2016 | PRGO | Buy Now | Perrigo | $26.56 | — | David Steinberg66% | — | Downgrade | Buy → Hold | Get Alert |
| 04/12/2016 | INSY | Buy Now | Insys Therapeutics | — | — | David Steinberg66% | $23 → $17 | Maintains | Buy | Get Alert |
| 03/23/2016 | AKRX | Buy Now | Akorn | — | — | David Steinberg66% | $43 → $35 | Maintains | Buy | Get Alert |
| 02/24/2016 | INSY | Buy Now | Insys Therapeutics | — | — | David Steinberg66% | $36 → $23 | Maintains | Buy | Get Alert |
| 02/08/2016 | SUPN | Buy Now | Supernus Pharmaceuticals | $32.10 | -43.93% | David Steinberg66% | → $18 | Upgrade | Hold → Buy | Get Alert |
| 01/19/2016 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Steinberg66% | → $31 | Initiates | → Buy | Get Alert |
| 10/23/2015 | PRGO | Buy Now | Perrigo | $26.56 | 686.9% | David Steinberg66% | $203 → $209 | Maintains | Buy | Get Alert |
| 08/07/2015 | INSY | Buy Now | Insys Therapeutics | — | — | David Steinberg66% | $32 → $50 | Maintains | Buy | Get Alert |
| 06/18/2015 | SUPN | Buy Now | Supernus Pharmaceuticals | $32.10 | -43.93% | David Steinberg66% | $11 → $18 | Upgrade | Hold → Buy | Get Alert |
| 05/15/2015 | HZNP | Buy Now | Horizon Therapeutics | — | — | David Steinberg66% | → $37 | Initiates | → Buy | Get Alert |
| 04/22/2015 | PRGO | Buy Now | Perrigo | $26.56 | 664.31% | David Steinberg66% | $187 → $203 | Maintains | Buy | Get Alert |
| 03/12/2015 | SUPN | Buy Now | Supernus Pharmaceuticals | $32.10 | -65.73% | David Steinberg66% | $9 → $11 | Maintains | Hold | Get Alert |
| 03/10/2015 | AKRX | Buy Now | Akorn | — | — | David Steinberg66% | $59 → $56 | Maintains | Buy | Get Alert |
| 02/27/2015 | AKRX | Buy Now | Akorn | — | — | David Steinberg66% | $49 → $50 | Maintains | Buy | Get Alert |
| 02/09/2015 | INSY | Buy Now | Insys Therapeutics | — | — | David Steinberg66% | $51 → $63 | Maintains | Buy | Get Alert |
| 01/20/2015 | AKRX | Buy Now | Akorn | — | — | David Steinberg66% | $44 → $49 | Maintains | Buy | Get Alert |
| 12/08/2014 | INSY | Buy Now | Insys Therapeutics | — | — | David Steinberg66% | → $51 | Initiates | → Buy | Get Alert |
| 08/15/2014 | PRGO | Buy Now | Perrigo Company | $26.56 | 562.65% | David Steinberg66% | $160 → $176 | Maintains | Buy | Get Alert |
| 04/21/2014 | SUPN | Buy Now | Supernus Pharmaceuticals | $32.10 | -71.96% | David Steinberg66% | → $9 | Initiates | → Hold | Get Alert |
| 04/21/2014 | AKRX | Buy Now | Akorn | — | — | David Steinberg66% | → $28 | Initiates | → Buy | Get Alert |
| 04/21/2014 | PRGO | Buy Now | Perrigo Company | $26.56 | 577.71% | David Steinberg66% | → $180 | Initiates | → Buy | Get Alert |
| 11/06/2013 | JAZZ | Buy Now | Jazz Pharmaceuticals | $114.45 | -3.89% | David Steinberg66% | $74 → $110 | Maintains | Buy | Get Alert |
| 03/05/2013 | SUPN | Buy Now | Supernus Pharmaceuticals | $32.10 | -59.5% | David Steinberg66% | → $13 | Initiates | → Buy | Get Alert |
| 04/27/2012 | JAZZ | Buy Now | Jazz Pharmaceuticals | $114.45 | -35.34% | David Steinberg66% | $64 → $74 | Maintains | Buy | Get Alert |
| 03/01/2012 | JAZZ | Buy Now | Jazz Pharmaceuticals | $114.45 | -51.07% | David Steinberg66% | $64 → $56 | Maintains | Buy | Get Alert |
